Principles of Cancer Treatment Flashcards

1
Q

What best describes tumour cell growth?

A
  • Gompertzian growth curve - 3 stages (lag, log, stationary)

- latent growth period is clinically SILENT

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What are the goals of cancer therapy?

A
  • if possible, to cure
  • maintain quality and duration of life
  • symptom relief for patients in palliative care
  • if all else fails, recruit into clinical trials
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What does high growth fraction mean?

A

many of the cells are actively dividing

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What does the slope of the curve depend on?

A
  • ratio of cell division to cell loss
  • growth fraction
  • TD (doubling time)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What has longer TD than the other?

A

Solid tumours have longer TD than hematological malignancies.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

How can metastasis occur?

A
  • blood

- lymphatic system

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What are some common metastatic sites?

A
  • liver
  • lung
  • lymph nodes
  • bone
  • brain
  • skin
  • adrenal glands
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What are the three types of cancer treatment?

A
  • surgery
  • radiation
  • chemotherapy
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What are some basic principles of cancer chemotherapy?

A
  • drug kills a constant proportion of tumour cells rather than a constant number of cells -> hence, repeat treatment cycles
  • smaller tumour gives better result due to higher growth fraction -> treat asap
  • chemotherapy has greatest effect on actively dividing cells
  • combination chemo can improve outcomes
  • drugs have narrow therapeutic index ->monitor pt
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

How are cancer treatments dosed?

A

According to body surface area (BSA)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

How do we intensify cancer treatments?

A
  • increase dose

- reduce interval between treatment cycles

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What are the drug-related factors affecting response to chemotherapy?

A
  • PK (ADME)
  • drug distribution to tumour microenvironment
  • mode of action
  • combination chemo
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What are some tumour-related factors affecting response to chemotherapy?

A
  • tumour growth kinetics (most successful with small tumour and high growth fraction)
  • tumour size (less effective on larger tumours)
  • site of tumour and tumour vascularization (sanctuary sites are CNS and testes; large tumours have central necrosis)
  • tumour cell heterogeneity - resistance (genetically unstable -> mutation gives rise to resistance)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What are some patient-related factors affecting response to chemotherapy?

A
  • pt overall health status
  • immuno-competency
  • organ functions - renal and hepatic
  • treatment history - prior exposure to chemotx and radiotx
  • patient’s age (caution in elderly)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What is neoadjuvant chemotherapy?

A
  • systemic tx given before surgery to debulk the tumour

- can also help to eradicate micro-metastases

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What is adjuvant chemotherapy?

A
  • administration of systemic tx to eradicate any residual micro-metastases and prevent them from becoming clinically evident disease
  • used together with surgery and or radiotx
  • aim is curative
17
Q

What is response rate?

A
  • percentage of pts who had regression following tx
  • complete response (CR) -> complete disappearance of all clinical evidence of tumour
  • partial response (PR) -> at least 50% decrease in tumour
  • disease progression (DP) -> increase of tumour >25%
  • stable disease

Overall response rate = CR + PR
Clinical benefit = CR + PR + SD

18
Q

What is karnofsky performance status?

A
  • 100% - normal, no complaints, no evidence of disease

- low number -> bad

19
Q

What is the ECOG performance status?

A
  • 0 is good

- 4 is bad